Xigduo

· AstraZeneca AB

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Xigduo, covering 2026-03-13 to 2026-06-05. Get the full timeline:

Most recent: EMA Authorised: Xigduo (metformin hydrochloride;dapagliflozin propanediol monohydrate) — AstraZeneca AB